-
Product Insights
NewLikelihood of Approval Analysis for Mutational Disorders
Overview How likely is it that the drugs in Mutational Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mutational Disorders Overview Mutational disorders, alternatively termed genetic or genomic disorders, stem...
-
Product Insights
NewLikelihood of Approval Analysis for Beta Thalassaemia
Overview How likely is it that the drugs in Beta Thalassaemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Beta Thalassaemia Overview Beta-thalassemia is a genetic blood disorder characterized by reduced...
-
Product Insights
NewLikelihood of Approval Analysis for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Overview How likely is it that the drugs in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. T-Cell Acute Lymphocytic Leukemia (T-Cell Acute...
-
Product Insights
NewLikelihood of Approval Analysis for Migraine
Overview How likely is it that the drugs in Migraine will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Migraine Overview Migraine is a genetically influenced complex neurological disorder characterized by episodes...
-
Product Insights
NewFragile X Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Fragile X Syndrome Clinical Trial Report Overview A total of 110 fragile X syndrome clinical trials were conducted as of March 2024. The fragile X syndrome clinical trial report provides a comprehensive understanding of the fragile X syndrome clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Uveal Melanoma
Overview How likely is it that the drugs in Metastatic Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and...
-
Product Insights
NewLikelihood of Approval Analysis for Retinal Degeneration
Overview How likely is it that the drugs in Retinal Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Degeneration Overview Retinal degeneration refers to a group of diseases that...
-
Product Insights
NewPolycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Polycystic Kidney Disease Clinical Trial Report Overview A total of 238 polycystic kidney disease clinical trials were conducted as of March 2024. The polycystic kidney disease clinical trial report provides a comprehensive understanding of the polycystic kidney disease clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions...
-
Product Insights
NewLikelihood of Approval Analysis for Myeloproliferative Disorders
Overview How likely is it that the drugs in Myeloproliferative Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myeloproliferative Disorders Overview MPDs are blood cancers caused by changes in the...
-
Product Insights
NewLikelihood of Approval Analysis for Retinitis Pigmentosa (Retinitis)
Overview How likely is it that the drugs in Retinitis Pigmentosa (Retinitis) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinitis Pigmentosa (Retinitis) Overview Retinitis pigmentosa refers to a group of...